Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Brophy

Showing results (61-70 of 242) with videos related to

Pageof 25
Sort By:
International Journal of Cardiology|April 21, 2024
Effect of bempedoic acid on mortality and cardiovascular events in primary and secondary prevention: A post-hoc analysis of the CLEAR-outcomes trialAhmed Sayed, James M Brophy
BMC Anesthesiology|June 27, 2007
Drotrecogin alfa (activated) in severe sepsis: a systematic review and new cost-effectiveness analysisVania Costa, James M Brophy
The New England Journal of Medicine|April 16, 2020
Complete Revascularization with Multivessel PCI for Myocardial InfarctionPeter Bogaty, James M Brophy
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 1, 2005
Medical decision making with incomplete evidence--choosing a platelet glycoprotein IIbIIIa receptor inhibitor for percutaneous coronary interventionsJames M Brophy, Lawrence Joseph
Lancet (London, England)|February 1, 2005
GRACIA: implications for clinical practicePeter Bogaty, James M Brophy
JAMA Internal Medicine|May 31, 2017
What to Do Following Fibrinolysis for ST-Elevation Myocardial Infarction: Reappraising Routine Percutaneous InterventionPeter Bogaty, James M Brophy
BMJ (Clinical Research Ed.)|July 21, 2017
Authors' reply to WicksMichèle Bally, James M Brophy
European Journal of Preventive Cardiology|July 1, 2022
Diabetes and atrial fibrillation: does the type of diabetes matter?Michelle Samuel, James M Brophy
The Journal of Thoracic and Cardiovascular Surgery|February 28, 2021
The controversy on the treatment of left main coronary artery diseaseMario Gaudino, James M Brophy
The Canadian Journal of Cardiology|June 18, 2023
Beta-Blockers, Digoxin, or Both Following an Incident Diagnosis of Atrial Fibrillation: A Prospective Cohort StudyJames M Brophy, Lyne Nadeau
Pageof 25

Showing results (61-70 of 242) with videos related to

Sort By:
Pageof 25
International Journal of Cardiology|April 21, 2024
Effect of bempedoic acid on mortality and cardiovascular events in primary and secondary prevention: A post-hoc analysis of the CLEAR-outcomes trialAhmed Sayed, James M Brophy
BMC Anesthesiology|June 27, 2007
Drotrecogin alfa (activated) in severe sepsis: a systematic review and new cost-effectiveness analysisVania Costa, James M Brophy
The New England Journal of Medicine|April 16, 2020
Complete Revascularization with Multivessel PCI for Myocardial InfarctionPeter Bogaty, James M Brophy
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 1, 2005
Medical decision making with incomplete evidence--choosing a platelet glycoprotein IIbIIIa receptor inhibitor for percutaneous coronary interventionsJames M Brophy, Lawrence Joseph
Lancet (London, England)|February 1, 2005
GRACIA: implications for clinical practicePeter Bogaty, James M Brophy
JAMA Internal Medicine|May 31, 2017
What to Do Following Fibrinolysis for ST-Elevation Myocardial Infarction: Reappraising Routine Percutaneous InterventionPeter Bogaty, James M Brophy
BMJ (Clinical Research Ed.)|July 21, 2017
Authors' reply to WicksMichèle Bally, James M Brophy
European Journal of Preventive Cardiology|July 1, 2022
Diabetes and atrial fibrillation: does the type of diabetes matter?Michelle Samuel, James M Brophy
The Journal of Thoracic and Cardiovascular Surgery|February 28, 2021
The controversy on the treatment of left main coronary artery diseaseMario Gaudino, James M Brophy
The Canadian Journal of Cardiology|June 18, 2023
Beta-Blockers, Digoxin, or Both Following an Incident Diagnosis of Atrial Fibrillation: A Prospective Cohort StudyJames M Brophy, Lyne Nadeau
Pageof 25